거성약품(주) / KEO SUNG PHRAM. CO., LTD.
KEO SUNG PHRAM. CO., LTD.'s KOBDi Score is 81.47 as of Sep 2026, down 11.08 points since Apr 2025; it rose in 1 and fell in 1 of the 12 monthly updates. As of Sep 2026 it is ahead of about 79% of companies in its industry, against 79% in Aug 2026 and 86% in Apr 2025. Its strongest position was 88% (Apr 2026) and its weakest 79% (Sep 2026).
A year earlier, in Aug 2025, its score was 92.55 and it was ahead of about 86% of companies in its industry.
| Sep 2026 | 81.47 | ahead of 79% |
| Aug 2026 | 81.47 | ahead of 79% |
| Jul 2026 | 81.47 | ahead of 79% |
| Jun 2026 | 92.71 | ahead of 87% |
| May 2026 | 92.71 | ahead of 87% |
| Apr 2026 | 92.71 | ahead of 88% |
| Mar 2026 | 92.71 | ahead of 87% |
| Feb 2026 | 92.71 | ahead of 87% |
| Dec 2025 | 92.71 | ahead of 87% |
| Aug 2025 | 92.55 | ahead of 86% |
| Jul 2025 | 92.55 | ahead of 86% |
| May 2025 | 92.55 | ahead of 86% |
| Apr 2025 | 92.55 | ahead of 86% |
Where is KEO SUNG PHRAM. CO., LTD. located?
KEO SUNG PHRAM. CO., LTD. is registered at 서울특별시 동대문구 답십리동, South Korea (postal code 130030).
What industry is KEO SUNG PHRAM. CO., LTD. in?
KEO SUNG PHRAM. CO., LTD. belongs to Wholesale & Retail Trade › Wholesale – Household Goods & Appliances › Pharmaceutical wholesaler.
What is KEO SUNG PHRAM. CO., LTD.'s KOBDi Score?
81.47 as of September 2026, ahead of about 79% of companies in its industry.
Who are KEO SUNG PHRAM. CO., LTD.'s competitors?
Similar companies include 현주케어, 다우팜 and 티제이약품.

